Europe Antibody Discovery Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Antibody Discovery Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Antibody Discovery Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Antibody Discovery Market Regional Analysis

6.2 Europe Antibody Discovery Market Revenue 2020-2030 (US$ Million)

6.3 Europe Antibody Discovery Market Forecast Analysis

7. Europe Antibody Discovery Market Analysis – by Antibody Type

7.1 Monoclonal Antibodies

7.1.1 Overview
7.1.2 Monoclonal Antibodies: Europe Antibody Discovery Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.2 Polyclonal Antibodies

7.2.1 Overview
7.2.2 Polyclonal Antibodies: Europe Antibody Discovery Market – Revenue and Forecast, 2020-2030 (US$ Million)

8. Europe Antibody Discovery Market Analysis – by Nature

8.1 Human and Humanized

8.1.1 Overview
8.1.2 Human and Humanized: Europe Antibody Discovery Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.2 Chimeric

8.2.1 Overview
8.2.2 Chimeric: Europe Antibody Discovery Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.3 Murine

8.3.1 Overview
8.3.2 Murine: Europe Antibody Discovery Market – Revenue and Forecast, 2020-2030 (US$ Million)

9. Europe Antibody Discovery Market Analysis – by End User

9.1 Pharmaceutical and Biotechnology Companies

9.1.1 Overview
9.1.2 Pharmaceutical and Biotechnology Companies: Europe Antibody Discovery Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.2 Research Laboratories

9.2.1 Overview
9.2.2 Research Laboratories: Europe Antibody Discovery Market – Revenue and Forecast, 2020-2030 (US$ Million)

10. Europe Antibody Discovery Market – Europe Analysis

10.1 Overview

10.2 Europe

10.2.1 Europe Antibody Discovery Market Breakdown, by Key Country, 2023 and 2030 (%)
10.2.1.1 Europe Antibody Discovery Market – Revenue and Forecast Analysis – by Country
10.2.1.1 UK: Europe Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.1.1 UK: Europe Antibody Discovery Market Breakdown, by Antibody Type
10.2.1.1.2 UK: Europe Antibody Discovery Market Breakdown, by Nature
10.2.1.1.3 UK: Europe Antibody Discovery Market Breakdown, by End User

10.2.1.2 Germany: Europe Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.2.1 Germany: Europe Antibody Discovery Market Breakdown, by Antibody Type
10.2.1.2.2 Germany: Europe Antibody Discovery Market Breakdown, by Nature
10.2.1.2.3 Germany: Europe Antibody Discovery Market Breakdown, by End User

10.2.1.3 France: Europe Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.3.1 France: Europe Antibody Discovery Market Breakdown, by Antibody Type
10.2.1.3.2 France: Europe Antibody Discovery Market Breakdown, by Nature
10.2.1.3.3 France: Europe Antibody Discovery Market Breakdown, by End User

10.2.1.4 Russia: Europe Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.4.1 Russia: Europe Antibody Discovery Market Breakdown, by Antibody Type
10.2.1.4.2 Russia: Europe Antibody Discovery Market Breakdown, by Nature
10.2.1.4.3 Russia: Europe Antibody Discovery Market Breakdown, by End User

10.2.1.5 Italy: Europe Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.5.1 Italy: Europe Antibody Discovery Market Breakdown, by Antibody Type
10.2.1.5.2 Italy: Europe Antibody Discovery Market Breakdown, by Nature
10.2.1.5.3 Italy: Europe Antibody Discovery Market Breakdown, by End User

10.2.1.6 Rest of Europe: Europe Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.6.1 Rest of Europe: Europe Antibody Discovery Market Breakdown, by Antibody Type
10.2.1.6.2 Rest of Europe: Europe Antibody Discovery Market Breakdown, by Nature
10.2.1.6.3 Rest of Europe: Europe Antibody Discovery Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Charles River Laboratories International Inc

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Creative Biolabs Inc

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Evotec SE

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Sartorius AG

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Aragen Life Sciences Ltd

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Twist Bioscience Corp

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Biocytogen Pharmaceuticals Beijing Co Ltd

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

Europe Antibody Discovery Market